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doi:10.1016/j.jtcvs.2005.09.037ackground: Chronic ischemic mitral regurgitation is associated with poor long-
erm survival. Despite the increasing popularity of valve repair, its durability and
ong-term outcome for ischemic mitral regurgitation have recently been questioned.
ethods: Seventy-eight patients underwent repair for ischemic mitral regurgitation
etween 1996 and 2002 at our institution. Of these patients, 73 had complete clinical
nd echocardiographic follow-up. Preoperative, intraoperative, and postoperative
linical data were obtained, and the results of echocardiograms were reviewed to
ssess the rate of recurrence of regurgitation after repair and to identify predictive
actors.
esults: The mean preoperative mitral regurgitation grade, New York Heart Asso-
iation class, and left ventricular ejection fraction were 2.72, 2.65, and 39.4%,
espectively. Mortality was 12.3% at 30 days and 30.1% at a mean follow-up of 39
25 months. Immediate postoperative echocardiography showed absent or mild
itral regurgitation in 89.4% of patients and showed moderate mitral regurgitation
n 10.6%. Freedom from reoperation was 93.2%. Recurrent moderate mitral regur-
itation (2) was present in 36.7% of patients, and severe mitral regurgitation (3
o 4) was present in 20.0% at mean follow-up of 28.1  22.5 months. Only age
P  .0130) and less marked preoperative posterior tethering (P  .0362) were
redictive of recurrent mitral regurgitation. Patients with a preoperative New York
eart Association class greater than II and recurrent mitral regurgitation greater than
 had decreased survival (P  .0152 and P  .0450, respectively).
onclusions: Significant recurrent mitral regurgitation occurs following repair for
schemic mitral regurgitation, despite good early results. This finding raises ques-
ions about the need for improved repair techniques, better patient selection, or
ventual mitral valve replacement in selected patients.
hronic ischemic mitral regurgitation (IMR) is generally defined as mitral
regurgitation (MR) secondary to myocardial infarction.1 IMR has been
shown to be an independent predictor of mortality,2-4 with reported survival
f 40% to 60% at 5 years.1,5-8 Operative mortality is increased for patients under-
oing mitral valve operation and revascularization in the presence of IMR when
ompared with nonischemic MR4,6,7 or revascularization alone.
Surgical correction, either by replacement or repair, is generally recommended
or 3 and 4 IMR.9-11 In comparative analyses, repair seems to benefit most
atients with IMR, with the possible exception of high-risk groups (higher New
ork Heart Association [NYHA] functional class or emergency operation).1,12 In
atients who undergo repair, residual MR greater than 1 is associated with
ncreased late mortality.13
Mitral valve repair, which most often involves the use of an undersized annu-
oplasty ring, has been shown to be effective, with 98% short-term success.1 Data
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CDoncerning MR recurrence after repair in patients with
egenerative mitral valve disease have recently been pub-
ished and show a significant incidence of late MR.14 Long-
erm results of repair for IMR are not defined, in part
ecause of underreporting of failure rates and because death
s an important competing end point in the evaluation of
epair failure. Although good results have been reported,15
igh recurrence rates of MR at follow-up have recently been
ublished, and this raises questions about the long-term
esults of mitral valve repair.5,16 Moreover, very few studies
ave evaluated predictors of recurrence.
Therefore, our objective was to analyze the incidence of
R recurrence after mitral valve repair for IMR and attempt
o define possible predictors of recurrence by looking at
reoperative, perioperative, and postoperative clinical and
chocardiographic data.
atients and Methods
ll patients who had mitral valve repair performed at the Montreal
eart Institute between 1996 and 2002 were considered. Seventy-
ight patients with MR resulting from myocardial infarction1 with
ormal mitral valve leaflets and chordae were identified. Of these
atients, 73 (94%) had long-term postoperative clinical and echo-
ardiographic follow-up and were included in the study.
atient Characteristics
he following patient data were analyzed: age; comorbidities
including hypertension, diabetes, and preoperative atrial fibrilla-
ion); extent of coronary artery disease on preoperative coronary
ngiogram (significant lesions were defined as50% narrowing of
major coronary artery); previous myocardial infarction, either
ecent (within 30 days before surgery) or old; left ventricular
jection fraction (LVEF) and NYHA functional class before sur-
ery and at last follow-up; repeat operation; associated valvular
esions; urgent operation (defined as within 48 hours of admis-
ion); and preoperative intra-aortic balloon pump use. Recent
yocardial infarctions were defined as a chest pain syndrome
ssociated with either ST segment elevation on the electrocardio-
ram or cardiac enzymes above the upper limit of normal. A prior
yocardial infarction was assumed if an akinetic segment was
bserved on the echocardiogram, with or without associated Q
aves on the electrocardiogram.
urgical Techniques
or intraoperative data, we analyzed bypass time, aortic cross-
Abbreviations and Acronyms
AVR  aortic valve replacement
IMR  ischemic mitral regurgitation
LV  left ventricle
LVEF  left ventricular ejection fraction
MR mitral regurgitation
NYHA New York Heart Associationlamp time, type of repair, annular size, associated procedures, t
66 The Journal of Thoracic and Cardiovascular Surgery ● Marcumber of grafts, adequacy of revascularization, postoperative
yocardial infarction (defined as creatine kinase MB 100 U/L),
nd early postoperative death (within 30 days or during the index
ospitalization). Revascularization was deemed complete only if
ll coronary arteries with significant lesions (50% stenosis) were
rafted, independent of artery caliber or segmental wall motion at
aseline.
chocardiographic Results
he results of immediate postoperative transesophageal or trans-
horacic echocardiograms within the first postoperative week were
ssessed for the presence and severity of early residual MR. After
mitral valve repair procedure at our institution, an echocardio-
raphic examination is performed before discharge, at 6 months,
nd then every 1 to 2 years. The severity of MR is graded on a
cale of 1 to 4 according to color jet area, pulsed wave–Doppler of
he pulmonary veins, and proximal isovelocity surface area ac-
ording to American Society of Electrocardiography guidelines.17
he results of preoperative and postoperative echocardiograms
ere obtained for the severity of MR (graded according to color jet
rea and pulsed wave–Doppler of the pulmonary veins), LVEF,
egional left ventricular (LV) function, LV end-diastolic and end-
ystolic dimensions, left atrial diameter, systolic pulmonary artery
ressure, and associated valvular lesions.
A subgroup of patients had both preoperative and postoperative
chocardiograms available for detailed analysis. Echocardiograms
ere reviewed by 1 observer for the severity of MR,17 as well as
or the direction of the regurgitant jet (central vs eccentric), LVEF,
egional LV wall motion, LV end-diastolic and end-systolic di-
ensions, left atrial dimensions, left atrial volume,18 the presence
f associated valvular lesions, and systolic pulmonary artery pres-
ure, as determined from the tricuspid regurgitant jet. The LV
phericity index was measured by calculating the ratio between the
V major axis and minor axis dimensions in the apical 4-chamber
iew.19-21 As this ratio decreases and approaches unity, the LV
ecomes more spherical. The mitral annular diameter was mea-
ured in the apical 4- and 2-chamber views, and the mean annular
iameter was calculated. The degree of anterior and posterior
ethering was estimated by measuring the distance between the
nterior mitral annulus and the anterior or posterior papillary
uscle tip, respectively (Figure E1). Tenting height and area were
lso measured.22
linical Follow-up
ollow-up was performed at a specialized valvular heart disease
utpatient clinic. Most patients were seen for follow-up, whereas a
ew patients were followed up through mail correspondence.
tatistical Analysis
atient characteristics and echocardiographic results are expressed
s means  SD or simple frequencies and percentages. Late
ortality was studied by using survival analysis. Survival curves
ere computed by using the Kaplan-Meier formulas and were
ompared between groups by using the log-rank test. Univariate
nd multivariate linear regression were used to identify predic-
ors of MR recurrence. To detect any differences between the
chocardiographic subgroup and the rest of the study popula-
ion, independent sample t tests were performed on normally
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CDistributed continuous variables, and the nonparametric Mann-
hitney test was used when distributional assumptions were
ot met. Paired-samples t tests were used to compare continu-
us variables from the echocardiographic subgroup. Statistical
nalysis was performed with the computer software SAS (SAS
nstitute Inc, Cary, NC).
esults
atient Characteristics
he baseline characteristics of the 73 patients are shown in
able 1. The mean age was 65 years, the mean ejection
raction was 39.4%  12.2%, and the average NYHA
unctional class was 2.65  0.81. Patients had a dilated LV
nd left atrium. The mean preoperative MR grade was 2.72;
oderate MR (2) was present in 37% of patients and
evere MR (3 and 4) in 63% (Figure 1). The operative
haracteristics of the patients are shown in Table 2. Coro-
ary artery bypass grafting was performed in 87.7% of
atients at the time of mitral valve repair, and among the 9
emaining patients, 5 had already undergone coronary artery
ypass grafting during a prior procedure. The other 4 did not
equire coronary artery bypass grafting because of either
atent or chronically occluded vessels.
Repair involved insertion of an undersized annuloplasty
ing in all patients; 2 patients also had an Alfieri stitch
ABLE 1. Baseline patient characteristics (n  73)
ariable Data
ge (y) 65  9.9
ale 49 (67)
BP 38 (52)
iabetes 24 (33)
trial fibrillation 26 (36)
VEF (%) 39.4  12.2
YHA class 2.65 0.81
0 0%
I 9 13%
II 25 34%
III-IV 39 53%
V diastolic diameter (mm) 58.2 6.5
V systolic diameter (mm) 44.3 8.0
A diameter (mm) 45.5 6.5
AP (mm Hg) 45.8 16.2
reoperative MR grade 2.72 0.51
CAD
One vessel 8 (11)
Two vessels 13 (18)
Three vessels 48 (66)
Recent MI 21 (29)
Previous MI 62 (85)
ata are n (%) or mean  SD. HBP, High blood pressure; LVEF, left
entricular ejection fraction; NYHA, New York Heart Association; LV, left
entricular; LA, left atrial; PAP, pulmonary artery pressure; MR, mitral
egurgitation; CAD, coronary artery disease; MI, myocardial infarction.rocedure performed. The degree of undersizing was not m
The Journal of Thoracicomogenously recorded in the 6-year period of the study.
en and large patients tended to receive a size 28 ring,
hereas women or smaller patients received a size 26 ring.
pecifically, a size 26 ring was used in 39%, size 28 in 44%,
ize 30 in 8%, size 32 in 7%, and size 34 in 2% of patients.
inety percent of patients had a rigid or semirigid complete
ing (79% Carpentier Physio rings, 2% Carpentier Classic
ings, Edwards Lifesciences, LLC, Irvine, Calif. 7% Annu-
oflo rings, Carbomedics, Sorin Group Company, Austin,
ex. and 2% Seguin rings, Edwards Lifesciences, LLC,
rvine, Calif.). A Cosgrove flexible posterior band was used
n 10% of patients. Repair was deemed successful in the
perating room if MR was equal to or less than 1.
Additional interventions were performed in a few pa-
ients: 6 patients had tricuspid annuloplasty for grade 3/4 or
reater regurgitation, 3 patients had LV operations (aneu-
ysm resection or a remodeling procedure), and 2 patients
ad aortic valve replacement (AVR). The outcome of pa-
ients who underwent LV operation or AVR was good, with
o early deaths and with mild MR at late follow-up. Patients
igure 1. Preoperative, early postoperative (within 30 days), and
id-term (28  22 months) follow-up MR grade.
ABLE 2. Operative characteristics (n  73)
ariable Data
eoperation 14 (19)
rgent operation 6 (8)
reoperative IABP 8 (11)
ypass time (min) 127.5 36.5
rossclamp time (min) 88.5 28.0
umber of grafts 2.2 1.2
ncomplete revascularization 26 (37)
nnular size (mm) 27.6 1.8
ostoperative MI 12 (16)
ata are n (%) or mean  SD. IABP, Intra-aortic balloon pump; MI,
yocardial infarction.
and Cardiovascular Surgery ● Volume 131, Number 3 567
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A
CDho had tricuspid annuloplasty had a worse outcome during
ollow-up: 2 died within 30 days after the operation, and 1
ied later. One patient required early mitral valve replace-
ent because of severe MR, and the remaining 2 patients
ad moderate MR at last follow-up.
urvival, Reoperation, and Clinical Follow-up
he early postoperative death rate, defined as death within
0 days after surgery or within the same hospitalization, was
2.3%. The mean survival follow-up was 39.3  25.0
onths. Actuarial survival was 85% at 1 year, 79% at 2
ears, and 68% at 5 years (Figure E2). Actuarial freedom
rom reoperation was 93.2%. At follow-up, the mean
YHA class was significantly improved, at 1.56  0.63
P  .0001); LVEF was not significantly changed, at 38.9%
12.9%. Neither was associated with the MR grade at
ollow-up.
ecurrence of MR
esults of an immediate postoperative transesophageal
chocardiogram or a transthoracic examination performed
ithin the first postoperative week were available in 90% of
he patients. Mild or absent MR (0 or 1) was observed in
9.4% of patients, whereas moderate MR (2) was noted in
0.6% (7 patients). No patient had severe MR (3 or 4)
n early postoperative echocardiogram (Figure 1). The evo-
ution of the 7 cases with early moderate MR was poor: 2
atients died within 3 months after surgery, 2 patients
equired mitral valve replacement, 2 patients had 2MR at
ast follow-up, and 1 patient improved to 1 MR.
Mid-term echocardiographic follow-up (28.1  22.5
onths) results were available in all 60 patients who sur-
ived the early postoperative period. At the last examination
vailable, moderate MR (2) was observed in 37% of our
atients, and severe MR (3 or 4) was observed in 20%
Figures 1 and E3). Recurrence of severe MR occurred both
arly and late, within 6 months after surgery in 5 patients
nd after 6 months in 7 patients. Five patients (8.3%)
equired reoperation, and all 5 received mitral valve replace-
ent (3 mechanical prostheses and 2 bioprostheses). The
nterval between initial operation and reoperation varied
rom 14 days to 38.5 months. Recurrent severe MR devel-
ped in the remaining 7 patients in a period ranging from 3
onths to 62 months after surgery, but they had not under-
one reoperation at last follow-up.
etailed Echocardiographic Analysis
chocardiographic results for the subgroup of 18 patients
ith preoperative and postoperative echocardiograms avail-
ble for detailed analysis are shown in Table 3. MR grade
ignificantly decreased with operation (P  .0001). There
as no significant change in LVEF, sphericity index, LV
r LA dimensions, or volumes between preoperative and t
68 The Journal of Thoracic and Cardiovascular Surgery ● Marcollow-up echocardiographic studies. There was a signif-
cant decrease in annular diameter (P  .0001) and mitral
alve tenting area (P .0113). Mitral anterior and posterior
ethering distances were increased before surgery but were
ot changed at follow-up.
The only preoperative variable that correlated with MR
rade at follow-up was the degree of posterior leaflet teth-
ring (P  .0362). A shorter preoperative tethering distance
as associated with a greater degree of recurrent MR. At
ollow-up, none of the postoperative variables correlated
ith MR severity. We also assessed whether the degree of
hange of echocardiographic variables was associated with
R grade at follow-up; no statistically significant correla-
ion was observed.
The baseline variables of the echocardiographic sub-
roup were compared with those of the overall study pop-
lation to see whether it was a representative subgroup. No
ignificant differences were observed for preoperative
R grade, postoperative MR grade, preoperative NYHA
lass, postoperative NYHA class, age, or postoperative
VEF (P  .05). Only preoperative LVEF differed be-
ABLE 3. Echocardiographic subgroup results (n  18)
ariable Before surgery After surgery P value
R grade 2.86 0.56 1.42 0.83 .0001
ccentric jet (%) 33 12 .05
VEF (%) 34.40 11.45 34.53 14.22 .75
V diastole (mm) 60.86 6.70 59.53 7.05 .34
V systole (mm) 44.83 7.09 45.00 9.85 .97
DV (mL) 147.78 40.03 131.17 44.16 .25
SV (mL) 106.22 38.28 99.00 43.47 .54
AD (PSLAX) (mm) 47.38 5.93 47.50 6.29 .95
ongitudinal LAD
(A4C) (mm)
62.61 11.59 59.50 8.69 .37
ransverse LAD
(A4C) (mm)
46.89 7.83 45.39 5.99 .51
A volume (mL) 79.44 28.42 72.77 28.05 .76
nnular diameter
(mm)
32.89 3.90 26.44 4.10 .0001
phericity index 1.35 0.32 1.29 0.30 .42
nterior tethering
distance (mm)
40.61 7.57 38.22 9.83 .41
osterior tethering
distance (mm)
39.39 8.44 39.22 6.91 .95
enting area (cm2) 1.48 0.44 1.09 0.35 .01
ent height (cm) 0.78 0.15 0.68 0.15 .09
ystolic PAP (mm
Hg)
46.13 15.22 40.38 10.49 .72
ata are mean  SD unless otherwise noted. MR, Mitral regurgitation;
VEF, left ventricular ejection fraction; LV, left ventricular; EDV, end-
iastolic volume; ESV, end-systolic volume; LAD, left atrial diameter; LA,
eft atrial; PAP, pulmonary artery pressure; PSLAX, parasternal long-axis;
4C, apical 4-chamber.ween the echocardiographic subgroup and the overall study
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A
CDroup (34.4% vs 40.9%, respectively), with borderline sta-
istical significance (P  .0487).
redictive Factors of Clinical Outcome and MR
ecurrence
n univariate analysis, only age was associated with MR
rade at follow-up (P  .0130), and preoperative LVEF
howed a borderline association (P  .06). No association
as observed for preoperative NYHA functional class, LV
imensions, eccentricity of the regurgitant jet, presence of a
ecent preoperative or postoperative myocardial infarction,
ncomplete revascularization, ring type, or annular size. In a
ultiple linear regression model including age and preop-
rative LVEF, age remained a statistically significant pre-
ictor of MR recurrence but not preoperative LVEF (P 
0336 and P  .1695, respectively; r2  .1312). MR grade
n early postoperative echocardiogram and MR grade at
ollow-up were not correlated (P  .1136).
Posterior leaflet tethering, being the only echocardio-
raphic variable significantly associated with MR grade at
ollow-up, a simple linear regression model was used on the
chocardiographic subgroup that showed the degree of pre-
perative posterior leaflet tethering to be a good predictor of
ate MR recurrence (P  .0362; r2  .2463). Patients with
posterior leaflet tethering distance less than 40 mm had a
reater degree of MR at follow-up (1.65 vs 0.8, respec-
ively; P  .0459).
The inclusion of timing of the mid-term echocardio-
raphic follow-up as a covariate in the multiple linear
egression model did not significantly alter any of these
esults. Kaplan-Meier survival curves showed that patients
ith a preoperative NYHA class greater than II and patients
ith recurrent MR greater than 2 had significantly higher
ortality rates (Figure 2). No association with survival was
bserved for age, preoperative LVEF, preoperative MR
rade, LV dimensions, or recent myocardial infarction.
iscussion
linical Outcome and MR Recurrence
his study illustrates the high recurrence rate of MR after
itral valve repair for IMR despite the use of a rigid
nnuloplasty ring and good early postoperative results. Sur-
ival was 85% at 1 year and 68% at 5 years, consistent with
revious studies,1,5,7 thus highlighting the negative progno-
is associated with IMR. Freedom from reoperation was
igh (93.2%), also consistent with the existing literature.1,5
owever, freedom from reoperation may overestimate the
uccess of a procedure, because many patients with less than
ptimal results will not undergo reoperation for various
easons, such as advanced age, poor residual LVEF, good
unctional class despite severe MR, comorbidities, or the
atient’s desire. Recurrence of MR is a more precise indi-
ator of procedural success but tends to be reported less
requently. The few published studies concerning postrepair p
The Journal of ThoracicR recurrence often have incomplete or short-term echo-
ardiographic follow-up.
Recently, McGee and colleagues5 observed that after an
nnuloplasty procedure for IMR, 28% of patients had re-
urrent grade 3 or 4MR by 6 months. In our study with
omplete echocardiographic follow-up, significant rates of
ecurrent MR were observed both early and late despite very
ood early postoperative results. This finding is in keeping
ith those of McGee and colleagues5 and of Tahta and
ssociates16 but is different from those of Bax and associ-
tes,15 who reported virtually no MR recurrence at 1.5
ears. A possible explanation for this difference is that
igure 2. Kaplan-Meier survival curves according to preoperative
YHA class (A) and postoperative MR grade (B). (A) N  73
atients. Time “0” represents date of surgery. (B) N  60 patients
aving survived to echocardiography. Time “0” represents date of
atest available echocardiogram.atients in the Bax study experienced reverse remodeling,
and Cardiovascular Surgery ● Volume 131, Number 3 569
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A
CDith significant decreases in LV and left atrial dimensions
nd improvement in LVEF; this was not shown in our group
f patients.
Our study illustrates the importance of long-term follow-up
hat includes imaging in evaluating the success of any valvular
peration. Some patients in our series experienced late
evere MR—as long as 5 years after the initial procedure—
hus emphasizing the need for continued clinical and echo-
ardiographic surveillance.
redictors of Recurrence
mong clinical factors, only age was predictive of recurrent
R, with a very weak correlation, however. The degree of
V dysfunction and the severity of preoperative MR did not
orrelate with the long-term success of the repair procedure.
ncomplete revascularization was not correlated with recur-
ent MR. In the treatment of IMR, ring annuloplasty has
een shown to be superior to suture annuloplasty.6,23 How-
ver, our results, in accordance with previously published
tudies,5,16 do not support an association between annulo-
lasty ring size and MR recurrence. Although no statistical
nalysis was performed because of the limited number of
atients who had a tricuspid annuloplasty, these patients had
worse clinical outcome than the overall group. This prob-
bly reflects a greater disease burden in patients requiring
his operation.
On early postoperative echocardiography, 89% of pa-
ients had mild or trivial MR, and no patient had severe MR;
his attests to the good early operative results. The MR
rade on early postoperative examination was not shown to
orrelate with the MR grade at follow-up. Only 7 patients
ad moderate MR on early postoperative echocardiogram,
nd although there was no statistically significant associa-
ion with the MR grade at follow-up, these patients seemed
o not fare as well as the overall group (among these 7
atients, 2 died early, and 2 required reoperations).
Patients with a preoperative NYHA class greater than II
ad higher mortality. There was no association between MR
everity at follow-up and NYHA functional class. Recurrent
R and survival are both time-dependent and competitive
nd points, and it is difficult to draw conclusions as to a
lear association between them. However, when early
eaths were excluded, the survival curves of patients with
ostoperative MR greater than 2 were worse than for
hose without significant MR recurrence, thus suggesting a
ossible association between the 2, as noted by others.24
chocardiographic Predictors of MR Recurrence
mong echocardiographic factors, the degree of preopera-
ive posterior leaflet tethering correlated with MR grade at
ollow-up. Leaflet tethering and local LV remodeling have
een established as the fundamental mechanisms involved
n IMR.25-29 It is important to note that patients in our study p
70 The Journal of Thoracic and Cardiovascular Surgery ● Marcad increased preoperative mitral leaflet tethering distances.
e observed an association between a decreased preoper-
tive posterior papillary muscle tip/anterior annulus dis-
ance and a higher MR grade at follow-up; ie, patients with
ess marked leaflet tethering had more recurrent MR. Pre-
iously published work by Kumanohoso and colleagues22
howed a greater posterior tethering distance to be indepen-
ently associated with MR severity. Theirs was a study
nvestigating MR incidence according to infarct location
nd involved mainly patients with mild MR. One possibility
o explain findings in our study is that patients with less
evere preoperative tethering may have fewer anomalies to
e corrected by reduction annuloplasty than patients with a
reater degree of tethering; thus, these patients may be more
rone to recurrence. Recent work by Agricola and col-
eagues30 has suggested a new echocardiographic classifi-
ation of IMR based on tethering pattern, either symmetric
r asymmetric, with potential therapeutic implications.
These observations add to the understanding of the com-
lex pathology of IMR, which is more complex than simple
nnular dilatation; thus, annuloplasty alone may not be the
ost appropriate treatment. The finding of high postrepair
ecurrence rates adds incentive to tailor therapy to each
atient’s pathologic characteristics.
otential Limitations
lmost all postoperative echocardiograms were per-
ormed at our institution, except for 9 patients who had
ostoperative studies performed in referring hospitals,
sually because of the long traveling distances required.
lthough this might be a cause for discrepancy for MR in
he moderate range, severe MR is exceptionally overre-
orted because our referring centers generally require
ystolic pulmonary vein flow reversal to report grade 3
r 4 MR. Echocardiographic data were retrospectively
nalyzed; however, echocardiograms are prospectively
erformed in our institution for patients undergoing mi-
ral valve repair, with particular attention directed toward
R recurrence and severity and LV function. Clinical
ata were prospectively collected. Our study may have
een underpowered to detect certain differences because
f the limited number of patients, in particular for the
chocardiographic subgroup analysis. The subgroup anal-
sis was performed on an unselected number of patients,
ho were comparable to the overall study population.
owever, all bias cannot be excluded.
The study does not permit firm recommendations regard-
ng indications or contraindications for IMR repair, repair
echnique, or valve replacement. However, the results show
high rate of MR recurrence and strongly suggest the need
o reevaluate patient selection and repair techniques to im-
rove long-term patient outcome.
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CDonclusions
ignificant recurrent MR occurs after mitral valve repair for
MR. Recurrence can occur both early and late, despite
ood initial surgical results. Postoperative MR was not
ssociated with NYHA class at follow-up but seems to be
elated to late mortality, thus suggesting the negative prog-
ostic significance of MR recurrence. This raises the ques-
ion of whether additional repair techniques or better patient
election are needed to improve outcomes. If patients with
nticipated repair failure could be identified, these patients
ould possibly benefit more from mitral valve replacement
r other repair techniques. Our findings emphasize the need
or long-term prospective studies that include echocardio-
raphic follow-up.
We thank Dr Ihor Dydra for his dedication and guidance, and
rs Manon Bellemare for her continued devotion to the MHI
alve Clinic.
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iscussion
r Robert Klautz (Leiden, The Netherlands). Dr Bouchard and
is group have presented their results on the surgical treatment of
schemic MR and have found a rather disappointing result: more
han 57% of patients had recurrent MR of grade 2 or more at
id-term follow-up. This is in strong contrast to our own experi-
nce from Leiden published in Circulation last year, in which only
out of 51 patients had a recurrence of MR grade 2 and no patientad a grade 3 or 4 at 2 years’ follow-up. In trying to reconcile these
and Cardiovascular Surgery ● Volume 131, Number 3 571
fi
o
i
3
e
a
c
e
p
N
s
f
o
m
d
m
I
r
v
r
a
r
r
o
c
h
r
t
y
s
m
h
d
s
b
p
f
a
T
s
a
h
b
t
p
v
d
w
t
o
a
o
o
r
n
o
c
i
p
y
r
c
t
n
s
e
f
t
s
a
n
fi
f
W
t
r
s
p
e
o
r
R
p
5
i
t
t
a
a
c
e
p
e
t
e
t
e
c
C
Surgery for Acquired Cardiovascular Disease Serri et al
5
A
CDndings, I have tried to find explanations, and I would like your
pinion on these thoughts.
First, there could be a difference in patient selection. Although
n our study, ejection fraction was somewhat lower than in yours—
1%—you have included patients with more than just pure isch-
mic MR. Five patients had either aortic valve surgery or LV
neurysm resection. I think those should be excluded. Otherwise I
annot find a difference in our patients, and I cannot find an
xplanation for your worse outcomes on the basis of a worse
atient population. If anything, our patients were a little sicker,
YHA class was lower, on the average, and LV dimensions were
lightly bigger. So this does not seem the cause of the difference.
Second, and now I come to a more fundamental point, we
ound evidence of a time-dependent reverse remodeling. About
ne third of the patients showed reverse remodeling already at 3
onths and another third at 18 months, and the final one third
idn’t show reverse remodeling. In your presentation, you did not
ention the change in LV dimensions, but from your manuscript
understand that there was no change. Our results with a lack of
ecurrent MR could, of course, be explained by the fact that the
entricles of our patients got smaller, but I would hypothesize the
everse. They became smaller because there was no recurrent MR,
nd you did not find reverse remodeling because you had recur-
ence of MR.
Now I come to my questions. Did you indeed find no signs of
everse remodeling, and do you agree that the high recurrence rate
f MR in your study might be the cause of that, rather than the
onsequence?
Dr Bouchard. Thank you for those very good comments. I
ave been looking very carefully at your data and also tried to
econcile the different results. In terms of patient selection, I think
hat we are dealing with slightly different patient populations, as
ou mentioned. Yours had a significantly lower ejection fraction to
tart with and larger ventricles. Our cohort had 29% of acute
yocardial infarction with 19% of reoperation and 8% of people
aving emergency surgery. I think that all those factors could
istinguish the populations.
In terms of the Alfieri and the AVR, the results would be
imilar if we excluded those 2 subgroups. The AVR patients have
een doing very well, with 1MR on follow-up. As for the Alfieri
atients, they are doing well clinically. They both had 2 MR at
ollow-up.
In terms of reverse remodeling, that was a very interesting
spect. We did not experience reverse remodeling in our series.
he ventricular dimensions and the ejection fractions were all
imilar from the preop stage to the delayed postop echo follow-up,
nd no reverse remodeling was found whether or not the patient
ad recurrent mitral regurgitation.
Now, in terms of having more recurrence, one hypothesis could
e as follows: if the ventricles in our series are not as dilated as
hey are in your series, combined with the fact that many of our
atients had acute myocardial infarction, that could leave us with
entricles with more room for negative remodeling or dilation
uring follow-up. That is just a hypothesis, because the patients
ith acute myocardial infarctions didn’t behave differently from
he rest of the cohort in terms of MR recurrence in our series.
Dr Klautz. Now, if the recurrence of MR is the cause of lackf reverse remodeling, then maybe we should look more carefully u
72 The Journal of Thoracic and Cardiovascular Surgery ● Marct your early results. You call them good, but immediately post-
peratively you already had a 10% 2 MR rate, which, in our
pinion, is not a good result. Our criteria for achieving a good
epair in these patients with a restrictive type of MR is absolutely
o residual MR in the OR [operating room] and a coaptation length
f at least 8 mm. If this is not achieved at the end of surgery, we
onsider replacing the ring and downsizing even further. By hold-
ng on to these principles of stringent downsizing, at discharge no
atient had more than trivial MR.
Our median ring size was 26, all complete rings, while from
our slides, your median ring size was 28, with some noncomplete
ings, which brings me to my next question. Did you check the
oaptation length at the end of surgery, and might it be possible
hat you did not achieve adequate treatment of the restriction by
ot downsizing despite the mere absence of MR at the end of
urgery?
Dr Bouchard. These are good points. As for the 2MR at the
arly postop echoes, those patients didn’t behave statistically dif-
erently from the patients with better perioperative echo results in
erms of MR recurrence at late follow-up. Obviously it is a small
ubgroup of patients, 7 patients. They tended, however, not to do
s well clinically. So I would support being very aggressive and
ot leaving those 2 behind. Among those 7 patients, 2 died in the
rst 3 months, and 2 had mitral valve replacement during the
ollow-up period.
As for coaptation surface, we didn’t specifically look at that.
e did look, however, at whether there was a difference or not in
erms of using a complete ring or a posterior band, and those
esults were similar in terms of recurrence.
Dr Klautz. Finally, I want to come back to the patients in our
eries who did not show reverse remodeling, about one third of the
atient group. These were the patients with the bigger preoperative
nd-diastolic dimension, and this was the most important predictor
f reverse remodeling. We could not analyze predictors of recur-
ent MR because there were none. When analyzing our results with
OC [receiver operating characteristic] curves, we found that a
reop end-diastolic dimension of 65 and end-systolic dimension of
1 are the optimal cutoff values below which reverse remodeling
s predictable. We therefore believe that when the heart is larger
han that, additional procedures should be employed. In Leiden, we
hink that for patients with end-diastolic dimensions between 65
nd 80 mm, additional CorCap placement could be a valuable
djunct. What are your thoughts on this subject?
Dr Bouchard. Well, we didn’t have any experience with
hordal shortening. It is certainly an interesting approach consid-
ring that leaflet tethering is at the center of this pathology. All our
atients had some form of leaflet tethering, and we happened in our
cho subgroups to find that the shorter tethering distance between
he posterior papillary muscle and the anterior annulus had some
ffect. I would assume that some form of treatment at the level of
he chordae could have an effect. We just didn’t have firsthand
xperience with those techniques.
Dr Klautz. I am sorry, I wasn’t talking about a chordal pro-
edure but an additional procedure on the ventricle itself, like a
orCap or a cardiac support device.
Dr Bouchard. We did not have experience with that ventric-
lar approach either.
h 2006
y
k
m
m
t
t
p
m
w
w
p
l
v
s
s
g
M
h
l
a
i
8
b
t
r
o
w
p
h
w
r
r
c
M
a
r
e
o
i
f
c
t
w
p
m
v
M
l
c
s
o
w
a
s
y
t
a
e
l
a
t
h
w
p
r
o
p
g
a
a
u
C
s
n
c
d
2
k
r
d
i
p
t
o
r
r
t
s
a
p
r
h
O
a
c
i
a
s
Serri et al Surgery for Acquired Cardiovascular Disease
A
CDDr Christopher Acar (Paris, France). Dr Bouchard, I enjoyed
our presentation. I think it would be dangerous to leave the room
eeping in mind that intraoperative echo is not a useful adjunct for
itral valve repair even though there are limitations in ischemic
itral valve insufficiency. In fact we don’t have any other reliable
est available in the operating room. Did you consider increasing
he sensitivity of the intraoperative echo by raising the systemic
ressure with vasoconstrictors?
Dr Bouchard. Well, we had some experience with that, like
ost centers, except that during the time span of this study, that
as not done in any routine or systematic fashion. But especially
ith ischemic MR or functional MR, we tried to challenge those
atients. We tried to challenge those patients with a decent after-
oad, probably a mean pressure in the 70 to 80 range, and also with
olume challenge to try to give them a filling pressure that is
imilar to what they had before their surgery.
These are very good points. In this study, we didn’t look
pecifically at whether challenging those patients in the OR would
ive our early postoperative results a more meaningful predictor of
R recurrence. However, a very large majority of those patients
ad zero regurgitation in the OR setting, which might make them
ess likely to have significant MR when we challenged them.
Dr Acar. There was no residual MR even with an increased
fterload?
Dr Bouchard. When that was done, which was not standard-
zed during that period of the study.
Dr Khalid Rasheed (Islamabad, Pakistan). I noticed that only
8% of your patients had associated coronary revascularization. I
elieve that for an ischemic MR repair to succeed, it is imperative
hat all patients be revascularized. Why did 12% not have any
evascularization, and could this be a factor in a higher recurrence
f mitral regurgitation in your series?
Dr Bouchard. This is a very good question. Some patients
ere already revascularized—they were reoperations—and a large
roportion of those patients had all their grafts patent. We did,
owever, look specifically at incomplete revascularization and
hether or not that would be part of why some of the patients had
ecurrent MR, and that didn’t seem to be associated with recur-
ence of MR.
Dr David Adams (New York, NY). I would just like to make 2
omments for your consideration. The first is about your grading of
R. You have a very qualitative scale. Can you tell us a little more
bout how these were graded? Were they blinded? Were they double
eviewed? How did you actually look at your postop MR grade?
Dr Bouchard. Most of the echoes, that means all the echoes
xcept 9, were done in our institution. The grading was dependent
n the specific echocardiographer reviewing the exam, but as an
nstitution, they tend to grade the mitral regurgitation in a similar
ashion. So the grade 1 MRs were those where the MR jet area
ompared to the left atrial area was below 20%; the 2MRs were
hose where the jet area was between 20% and 40%; the 3 MRs
ere those where the jet area was above 30% and had systolic
ulmonary reflux; and the grade 4 would be kept for those with
ore than 40% of the MR jet area as well as systolic pulmonary
ein reversal. That is a pretty strict and severe way of looking at
R. In the 18 patients of the echo subgroups, the tapes were
ooked at by only 1 echocardiographer, and these were the same
riteria used during these evaluations. r
The Journal of ThoracicDr Adams. I would recommend that you go back and have the
ame echocardiographer review all of your echoes. I know several
f us have done this internally, and it is surprising what happens
hen you have 1 echocardiographer in your institution go back
nd relook at your official echo reports when you are using
emiquantitative or qualitative echo grades.
The second question I have is specifically about sizing, because
our results are different than several experiences, not so much in
erms of recurrent MR, because very little has been published
bout that, but in terms of residual MR with a downsized remod-
ling ring, that in fact has been shown in several series to be very
ow, and can you tell us again exactly how you size these rings,
nd how did you decide the 80% that got a remodeling ring versus
he 20% that didn’t?
Dr Bouchard. These are good questions. First, in answer to
aving all the echoes reviewed by the same person, that is what
as aimed at, and only a small part of the echoes were actually
hysically available for review. So the rest had to go with what
eports were available.
In terms of ring sizing, those surgeries were done by a variety of
ur staff surgeons, some preferring at the time a posterior band, some
referring a Carpentier Physio ring. I cannot speak for all the sur-
eons, but very often the ring sizing was aimed at reducing by 2 sizes
nd ended up being size 26 for women and size 28 for men. As
group, we moved mainly to use a complete ring and moved to
se either the Carbomedics Annuloflo or the Carpentier-Mc-
arthy-Adams rings, which have, as you well know, a shorter
eptolateral distance, and I think that is an important issue.
Dr Adams. I would just again reiterate what you said, that you
eed to downsize these rings, and you need to go back as best you
an, if you can, and tell us what percent of these rings were truly
ownsized, because the concept of just saying I am going to put a
8 in men and a 26 in women, that may not be downsizing. As you
now, a lot of men may need a 24 Physio ring or a 26; this new
ing that is downsized really is a dimension of 24 in the P3
imension. So I would not say that just saying we are using a 28
n men really correlates to downsizing.
Dr Harold Roberts (Lauderdale Lakes, Fla). I enjoyed your
resentation and your unflinching honesty. I do think that your less-
han-stellar results are partially self-inflicted, however. I believe 12%
f your patients had an incomplete ring implanted. I personally have
eoperated on 4 patients initially done by other surgeons that have had
epairs for ischemic MR with Cosgrove bands that looked great when
hey went out of the OR and then a few months later they were leaking
ubstantially. It is now well known that dilatation of the anterior
nnulus as well as reduction of the septal-lateral dimension are im-
ortant concepts best accomplished by a complete, probably semirigid
ing like the ET Logix or Physio.
The other thing that nobody really mentioned but that I think is
elpful so that you can have zero or trace MR coming out of the
R is to close the naturally occurring scallops between P1 and P2
s well as between P2 and P3. This can be done with 2 rows of
ontinuous 5-0 Cardionyl. Though it takes a few extra minutes, it
s the often difference between trace and zero mitral regurgitation
t the end of the procedure. Zero regurgitation should be the goal
o that a margin of safety is present should there be any deterio-
ation of the repair with time.
and Cardiovascular Surgery ● Volume 131, Number 3 573
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Figure E2. Kaplan-Meier survival for the overall study group.73.e1 The Journal of Thoracic and Cardiovascular Surgery ● March 2006
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